Efficacy and Safety of VNS Therapy or Continued Medication Management for Treatment of Adults with Drug-Resistant Epilepsy: Systematic Review and Meta-Analysis
Vagus nerve stimulation (VNS) Therapy® is an adjunctive neurostimulation treatment for people with drug-resistant epilepsy (DRE) who are unwilling to undergo resective surgery, have had unsuccessful surgery or are unsuitable for surgery. A systematic review and meta-analysis were conducted to determ...
Saved in:
Published in | Journal Of Neurology |
---|---|
Main Authors | , , , , , , , , |
Format | Book Review |
Language | English |
Published |
Durham
Research Square
05.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Vagus nerve stimulation (VNS) Therapy® is an adjunctive neurostimulation treatment for people with drug-resistant epilepsy (DRE) who are unwilling to undergo resective surgery, have had unsuccessful surgery or are unsuitable for surgery. A systematic review and meta-analysis were conducted to determine the treatment effects of VNS Therapy as an adjunct to anti-seizure medications (ASMs) for the management of adults with DRE. A literature search was performed in August 2020 of the Medline®, Medline® Epub Ahead of Print, Embase, and the Cochrane library databases. Outcomes examined included reduction in seizure frequency, seizure freedom, ASM load, discontinuations, and serious adverse events (SAEs). Comparators included best medical practice, ASMs, low-stimulation or sham VNS Therapy. Four RCTs and six comparative observational studies were identified for inclusion. Against comparators, individuals treated with VNS had a significantly better odds of experiencing a ≥50% reduction in seizure frequency (OR: 2.27 [95% CI: 1.47, 3.51]; p=0.0002), a ≥75% reduction in seizure frequency (OR: 3.56 [95% CI: 1.59, 7.98]; p=0.002) and a reduced risk for increased ASM load (risk ratio: 0.36 [95% CI: 0.21, 0.62]; p=0.0002). There was no difference in the odds of discontinuation or the rate of SAEs between VNS versus comparators. This meta-analysis demonstrated the benefits of VNS Therapy in people with DRE, which included improvement in seizure frequency without an increase in the rate of SAEs or discontinuations, thereby supporting the consideration of VNS Therapy for people who are not responding to ASMs and those unsuitable or unwilling to undergo surgery. |
---|---|
AbstractList | Vagus nerve stimulation (VNS) Therapy® is an adjunctive neurostimulation treatment for people with drug-resistant epilepsy (DRE) who are unwilling to undergo resective surgery, have had unsuccessful surgery or are unsuitable for surgery. A systematic review and meta-analysis were conducted to determine the treatment effects of VNS Therapy as an adjunct to anti-seizure medications (ASMs) for the management of adults with DRE. A literature search was performed in August 2020 of the Medline®, Medline® Epub Ahead of Print, Embase, and the Cochrane library databases. Outcomes examined included reduction in seizure frequency, seizure freedom, ASM load, discontinuations, and serious adverse events (SAEs). Comparators included best medical practice, ASMs, low-stimulation or sham VNS Therapy. Four RCTs and six comparative observational studies were identified for inclusion. Against comparators, individuals treated with VNS had a significantly better odds of experiencing a ≥50% reduction in seizure frequency (OR: 2.27 [95% CI: 1.47, 3.51]; p=0.0002), a ≥75% reduction in seizure frequency (OR: 3.56 [95% CI: 1.59, 7.98]; p=0.002) and a reduced risk for increased ASM load (risk ratio: 0.36 [95% CI: 0.21, 0.62]; p=0.0002). There was no difference in the odds of discontinuation or the rate of SAEs between VNS versus comparators. This meta-analysis demonstrated the benefits of VNS Therapy in people with DRE, which included improvement in seizure frequency without an increase in the rate of SAEs or discontinuations, thereby supporting the consideration of VNS Therapy for people who are not responding to ASMs and those unsuitable or unwilling to undergo surgery. |
Author | Conry, Joan Mitchell, Stephen Barion, Francesca Danielson, Vanessa Radtke, Rodney Batson, Sarah Shankar, Rohit Murphy, Joanna Boggs, Jane |
Author_xml | – sequence: 1 givenname: Sarah surname: Batson fullname: Batson, Sarah – sequence: 2 givenname: Rohit surname: Shankar fullname: Shankar, Rohit – sequence: 3 givenname: Joan surname: Conry fullname: Conry, Joan – sequence: 4 givenname: Jane surname: Boggs fullname: Boggs, Jane – sequence: 5 givenname: Rodney surname: Radtke fullname: Radtke, Rodney – sequence: 6 givenname: Stephen surname: Mitchell fullname: Mitchell, Stephen – sequence: 7 givenname: Francesca surname: Barion fullname: Barion, Francesca – sequence: 8 givenname: Joanna surname: Murphy fullname: Murphy, Joanna – sequence: 9 givenname: Vanessa surname: Danielson fullname: Danielson, Vanessa |
BookMark | eNqNjs2KwkAQhHPQw_rzDg17Dogahb2JRrzEgwlepUl6dJbYE2d6lHkaX9VBfABPRVFfFTVIemyYfpJnrpSusQ6A3ECJiiSAUXDcl1BdyGIXrYW1YdHsqYGCmsiLNgwFMp7pSiygIlNZQnm72F81vhUHDy0X2Fh_Tg_ktBOMad7pljoX_qAMTugax2o40F3T432iIMF0xdiG2BglfYWto_FHh8nvNq_Wu7Sz5ubJyenfeBthd5ouJ9k8W8wn2ew76gUsxFgd |
ContentType | Book Review |
Copyright | 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 3V. 7XB 88I 8FK AAFGM ABUWG ADZZV AFKRA AFLLJ AFOLM AGAJT AQTIP AZQEC BENPR CCPQU DWQXO GNUQQ HCIFZ M2P PIMPY PQCXX PQEST PQQKQ PQUKI PRINS Q9U |
DatabaseName | ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central Korea - hybrid linking ProQuest Central (Alumni) ProQuest Central (Alumni) - hybrid linking ProQuest Central SciTech Premium Collection - hybrid linking ProQuest Central Student - hybrid linking ProQuest Central Essentials - hybrid linking ProQuest Women's & Gender Studies - hybrid linking ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) Science Journals (ProQuest Database) Publicly Available Content Database ProQuest Central - hybrid linking ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
DatabaseTitle | Publicly Available Content Database ProQuest Science Journals (Alumni Edition) ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Genre | Review |
GroupedDBID | 3V. 7XB 88I 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ HCIFZ M2P PIMPY PQEST PQQKQ PQUKI PRINS Q9U |
ID | FETCH-proquest_journals_27054564053 |
IEDL.DBID | BENPR |
IngestDate | Tue Sep 24 21:59:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-proquest_journals_27054564053 |
OpenAccessLink | https://www.proquest.com/docview/2705456405/abstract/?pq-origsite=%requestingapplication% |
PQID | 2705456405 |
PQPubID | 4965281 |
ParticipantIDs | proquest_journals_2705456405 |
PublicationCentury | 2000 |
PublicationDate | 20220105 |
PublicationDateYYYYMMDD | 2022-01-05 |
PublicationDate_xml | – month: 01 year: 2022 text: 20220105 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | Durham |
PublicationPlace_xml | – name: Durham |
PublicationTitle | Journal Of Neurology |
PublicationYear | 2022 |
Publisher | Research Square |
Publisher_xml | – name: Research Square |
Score | 2.4609597 |
Snippet | Vagus nerve stimulation (VNS) Therapy® is an adjunctive neurostimulation treatment for people with drug-resistant epilepsy (DRE) who are unwilling to undergo... |
SourceID | proquest |
SourceType | Aggregation Database |
SubjectTerms | Convulsions & seizures Drug resistance Surgery Systematic review |
Title | Efficacy and Safety of VNS Therapy or Continued Medication Management for Treatment of Adults with Drug-Resistant Epilepsy: Systematic Review and Meta-Analysis |
URI | https://www.proquest.com/docview/2705456405/abstract/ |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGdoETCBCPgSzBNWqbruvKBfHoNCFtQmtBu01JmiIu7bZ2h_0a_ipx17ID0s5RosRKbOez_RngPqC4Ie9zlgwkZ8biB2wgHMFc6btKOdzRVfeG8aQ_-ui9zbxZC0ZNLQylVTY6sVLUSa4II7e4b5OxN_6FJSShAKq0HhdLRv2jKM5aN9M4gA53ehSw7TyHk_fpPxVb2Y3hMRxRLQFuAfgTaOnsFH5CYm0QaoPmE4-RSHW5wTzFz0mE8bbGH_MVEm3Ud7bWCW5jKSRA3CWroHE2MW6yxGn-EzFpFEjAKr6u1l9sqgtyDs1ouDBvf1FsHjD6I26uN1VtYqxLwRp6kjO4G4bxy4g1J5rX962Y76TjnkM7yzN9ASg8oROlXBlIaiwtBypQIu0L205dz0-CS-juW-lq__A1HHIqBSA4wutCu1yt9Y0x0KW8rWX_C-Blnq0 |
link.rule.ids | 314,786,790,798,21416,33779,43840 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLZgOwAnECAeAyzBNWJr163lgnh0KrBWaCtotylN04lLW_o47NfwV4m7lh2Qdo4S5Wk7n-3PADcW-Q21gcZCM9CY0vgWM3mPMz0Y6kL0tJ6sqje43sD56L_OjFkNuOV1WGUjEytBHSaCMPJbbdglZa_si_v0m1HVKPKu1iU0tqHd19VXpQXtR9t7n_wTrJW2GO3DHmUQ4Ap2P4AtGR_Cj01cDVwsUX3dccojWSwxifDTm6K_yuzHJEMii_qKSxniyoNC24brEBVUJib6TWw49X8g_owcCU7F56xcsInMySRUrXaqXnyaL-9w-kfXXE-qmoQrC84aUpIjuB7Z_pPDmhXN61uWz9d7oh9DK05ieQLIDS5DIfTACqicdGAKS_BowLvdSDeGoXUKnU0jnW1uvoIdx3fH8_GL93YOuxolAxAgYXSgVWSlvFAquggu63P4BR3OneA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+Safety+of+VNS+Therapy+or+Continued+Medication+Management+for+Treatment+of+Adults+with+Drug-Resistant+Epilepsy%3A+Systematic+Review+and+Meta-Analysis&rft.jtitle=Journal+Of+Neurology&rft.au=Batson%2C+Sarah&rft.au=Shankar%2C+Rohit&rft.au=Conry%2C+Joan&rft.au=Boggs%2C+Jane&rft.date=2022-01-05&rft.pub=Research+Square |